Fetzima on Blue Cross MedicareRx Value (S5715-001)
levomilnacipran hydrochloride
Covered.
Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.
$176.77
Patient pays / month, after deductible
$552.42
Patient pays / month, before the $615.00 deductible
$530.32
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
FETZIMA 120 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $552.42 for a month. Other covered strengths are listed below.
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| FETZIMA 120 mg Capsule, Extended Release | 4 | $176.77 | 30 per 30 days |
| FETZIMA 20 mg Capsule, Extended Release | 4 | $177.49 | 30 per 30 days |
| FETZIMA 40 mg Capsule, Extended Release | 4 | $179.07 | 30 per 30 days |
| FETZIMA 80 mg Capsule, Extended Release | 4 | $177.62 | 30 per 30 days |
| FETZIMA Kit | 4 | $179.65 | 28 per 28 days |
Verify with the plan before prescribing or filling. Member services: (888)285-2249. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5715-001